MinervaX ApS, a privately held Danish biotechnology company developing a novel, prophylactic vaccine against Group B Streptococcus (GBS), ...

Veeva Systems (NYSE: VEEV) today announced that leaders from Almirall, AstraZeneca, Bayer AG, BioNTech SE, Glenmark, and GSK ...

The ice cream maker then sued Unilever for selling its business in Israel to its licensee there, which allowed marketing in the West Bank and Israel to continue. That lawsuit was settled in 2022. In ...

GSK Plc said its blood cancer drug significantly reduced the risk of death when combined with another cancer treatment, ...

South Florida emerges as a life sciences business hub. Transpire Bio is expanding its global ... previously president and CCO ...

Dominic Walsh, a business reporter who previously covered the leisure and drinks industry for The Times from 1997 to 2024, stated in post to X: ...

As a wave of patent expirations encroaches upon many of the world’s top drugmakers, companies will need to be diligent in ...

--(BUSINESS WIRE)--Innoviva, Inc. (NASDAQ ... Innoviva’s royalty portfolio includes respiratory assets partnered with Glaxo Group Limited (“GSK”). Innoviva is entitled to receive royalties from GSK on ...

In addition, under our GSK collaboration, we recorded a non-cash reduction to ... and our expectations regarding the impact of any potential global macro events on our business. Actual results may ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

The business restructuring is expected to substantially reduce ... as well as lower research services revenue as the GSK Plc ...

SUNNYVALE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and preventive health company, ...